# Coverage Policy Requirements Quality Checklist: TDD Adoption

**Purpose**: Validation of coverage policy requirements quality—measurement definitions, target enforcement, exception processes, dashboards, and reporting. Tests whether coverage requirements are clear, measurable, and consistently applied across phases.

**Created**: 2025-11-11  
**Feature**: [spec.md FR-009, §Phased Rollout](../spec.md) | [plan.md Phases 0–3](../plan.md) | [contracts/coverage-policy.md](../contracts/coverage-policy.md)  
**Focus**: Coverage targets, measurement methodology, gating decisions, exception handling, team communication  
**Depth**: Comprehensive (40–55 items)  
**Risk Emphasis**: Fairness (legacy vs new code) > Clarity (unambiguous criteria) > Automation (tooling simplifies enforcement)

---

## Coverage Definition & Measurement

- [ ] CHK-COV001 - Is "line coverage" quantitatively defined (statements executed / total statements)? [Clarity, Spec FR-009]
- [ ] CHK-COV002 - Is "branch coverage" definition included (if applicable), and is it distinct from line coverage? [Clarity, Plan Open Question]
- [ ] CHK-COV003 - Is the coverage measurement tool specified (lcov on Linux, alternatives on other platforms)? [Completeness, Plan Phase 1]
- [ ] CHK-COV004 - Are exclusions from coverage documented (e.g., JUCE library code, generated code, platform-specific blocks)? [Completeness, Plan Phase 1]
- [ ] CHK-COV005 - Is the per-file coverage granularity specified (track coverage by component/file, not just overall)? [Clarity, Plan Phase 1]
- [ ] CHK-COV006 - Is the "critical flow" vs "non-critical" distinction for coverage calculation documented? [Clarity, Spec Assumptions]
- [ ] CHK-COV007 - Are edge cases/error paths counted toward coverage, or separately tracked? [Gap]
- [ ] CHK-COV008 - Is the handling of platform-specific code documented (count or exclude #if JUCE_MAC blocks)? [Clarity, Plan Phase 0]

---

## Phase-Based Coverage Targets

### Phase 0 (Week 1) Targets

- [ ] CHK-COV009 - Is the 90% "critical flow" coverage target for Phase 0 quantitatively defined (happy path + N error cases)? [Clarity, Spec FR-009, CHK057 note]
- [ ] CHK-COV010 - Is the acceptance criteria for "critical flow covered" explicitly specified (e.g., all 10 flows have ≥1 test)? [Clarity, Plan Phase 0]
- [ ] CHK-COV011 - Are the 10 critical flows explicitly enumerated in Phase 0 scope? [Completeness, Plan Phase 0]
- [ ] CHK-COV012 - Is the measurement method for Phase 0 coverage specified (manual checklist vs automated)? [Clarity, Plan Phase 0]

### Phase 1 (Weeks 2–3) Targets

- [ ] CHK-COV013 - Is the 50% overall line coverage target for Phase 1 measurable and tracked? [Completeness, Spec FR-009, Plan Phase 1]
- [ ] CHK-COV014 - Is it documented that Phase 1 coverage is "informational" (no gate enforcement yet)? [Clarity, Spec Phased Rollout]
- [ ] CHK-COV015 - Is the per-platform coverage reporting requirement specified for Phase 1 (separate % per macOS/Windows/Linux/iOS)? [Gap]

### Phase 2 (Weeks 4–6) Targets

- [ ] CHK-COV016 - Is the 70% overall line coverage target for Phase 2 measurable and tracked? [Completeness, Spec FR-009, Plan Phase 2]
- [ ] CHK-COV017 - Is the soft gate requirement documented (warn on <70%, but can merge with approval)? [Completeness, Spec Phased Rollout, Plan Phase 2]
- [ ] CHK-COV018 - Is the approval authority for soft gate overrides specified (maintainer, team lead)? [Gap]
- [ ] CHK-COV019 - Is the soft gate signal mechanism documented (PR comment, check failure/warning)? [Gap]
- [ ] CHK-COV020 - Is the override rationale tracking requirement specified (document why approved despite low coverage)? [Gap]

### Phase 3 (Weeks 7–8) Targets

- [ ] CHK-COV021 - Is the 80% line coverage target for new code (Phase 3) measurable and enforced? [Completeness, Spec FR-009, Plan Phase 3]
- [ ] CHK-COV022 - Is "new code" definition clear (modified files, new files, or both)? [Clarity, Plan Phase 3]
- [ ] CHK-COV023 - Is the hard gate requirement documented (new code <80% blocks merge, no override)? [Completeness, Spec FR-009, Plan Phase 3]
- [ ] CHK-COV024 - Is the legacy code coverage requirement specified (must reach 60% minimum, timeline by Week 8)? [Completeness, Plan Phase 3]

### Phase 4+ (Week 9+) Targets

- [ ] CHK-COV025 - Is the sustained 80%+ coverage requirement documented? [Completeness, Plan Phase 4]
- [ ] CHK-COV026 - Is the optional 85% target documented as aspirational for Phase 4+? [Clarity, Plan Phase 4]

---

## Exception Handling & Bypass Processes

### Exception Request Workflow

- [ ] CHK-COV027 - Is the coverage exception request process documented (GitHub Issue template, required fields)? [Completeness, Plan Phase 3]
- [ ] CHK-COV028 - Are required fields in exception template specified (rationale, justification, metrics)? [Gap]
- [ ] CHK-COV029 - Is the review process for exceptions documented (who approves, SLA for decision)? [Gap]
- [ ] CHK-COV030 - Is the exception approval authority specified (e.g., 2 maintainers)? [Gap]
- [ ] CHK-COV031 - Is the exception duration specified (temporary for release, permanent with review, etc.)? [Gap]
- [ ] CHK-COV032 - Is the exception tracking requirement documented (issues labeled, dashboard visibility)? [Gap]

### Performance-Critical Path Exceptions

- [ ] CHK-COV033 - Are performance-critical path exceptions defined (rare, case-by-case per plan)? [Clarity, Plan Phase 2]
- [ ] CHK-COV034 - Is the criteria for "performance-critical" specified (affects latency <10ms requirement)? [Clarity, Plan Phase 2]
- [ ] CHK-COV035 - Is the approval process for performance exceptions distinct from normal exceptions? [Gap]
- [ ] CHK-COV036 - Is the documentation requirement for performance exceptions specified (why untestable, alternative validation)? [Gap]

### Legacy Code Remediation Exceptions

- [ ] CHK-COV037 - Is the legacy code exception process documented (reaching 60% minimum by Week 8)? [Completeness, Plan Phase 3]
- [ ] CHK-COV038 - Are the priority levels for legacy code remediation specified (high-risk vs low-risk components)? [Gap]
- [ ] CHK-COV039 - Is the timeline for legacy code clearance documented (tracked tickets, required by Week 8)? [Completeness, Plan Phase 3]

---

## Coverage Reporting & Visibility

### Dashboards & Metrics

- [ ] CHK-COV040 - Is the coverage dashboard requirement documented (where are metrics published)? [Gap, Plan Phase 2+]
- [ ] CHK-COV041 - Are coverage trending metrics required (historical %, trend line, targets)? [Gap, Plan Phase 2+]
- [ ] CHK-COV042 - Is per-component coverage breakdown required (identify low-coverage areas)? [Gap, Plan Phase 1+]
- [ ] CHK-COV043 - Is per-platform coverage breakdown required (show variance across macOS/Windows/Linux)? [Gap]
- [ ] CHK-COV044 - Is plugin format coverage tracking required (VST3, AU, LV2 separately)? [Gap, Plan Phase 2+]

### Weekly & Monthly Reporting

- [ ] CHK-COV045 - Is the weekly coverage report requirement documented (format, distribution, timing)? [Gap, Plan Phase 4]
- [ ] CHK-COV046 - Is the recipient list specified (team, Discord, maintainers)? [Gap]
- [ ] CHK-COV047 - Is the monthly retrospective requirement documented (review trends, identify gaps)? [Partially, Plan Phase 4]
- [ ] CHK-COV048 - Are the metrics included in monthly review specified (coverage %, exceptions, trends)? [Gap]

### PR-Level Reporting

- [ ] CHK-COV049 - Is the PR comment requirement for coverage impact documented (show delta vs baseline)? [Gap, Plan Phase 2]
- [ ] CHK-COV050 - Is the format of coverage comments specified (table, inline, summary)? [Gap]
- [ ] CHK-COV051 - Is the trigger for coverage comments defined (only on low-coverage PRs, all PRs, etc.)? [Gap]

---

## Anti-Patterns & Quality Safeguards

### Coverage Gaming Prevention

- [ ] CHK-COV052 - Are "empty test" anti-patterns documented (tests with no assertions)? [Gap, Plan contracts/coverage-policy.md ref]
- [ ] CHK-COV053 - Is the requirement for meaningful assertions documented (at least 1 per test)? [Gap]
- [ ] CHK-COV054 - Are "mutation testing" or branch coverage review requirements mentioned for quality assurance? [Gap]
- [ ] CHK-COV055 - Is peer review emphasis on test quality (not just quantity) documented? [Gap]

### Flaky Test Management

- [ ] CHK-COV056 - Are flaky tests excluded from coverage calculations documented (or marked separately)? [Gap]
- [ ] CHK-COV057 - Is the quarantine process requirement documented (tests marked WILL_FAIL not counted against coverage)? [Completeness, Plan Phase 3]
- [ ] CHK-COV058 - Are exclusion criteria for "broken test" documented (vs flaky vs legitimately skipped)? [Gap]

---

## Tools & Automation

### Coverage Measurement Tools

- [ ] CHK-COV059 - Is the coverage tool configuration documented (lcov flags, filters, exclusions)? [Gap]
- [ ] CHK-COV060 - Is the coverage tool validation requirement documented (output format, accuracy)? [Gap]
- [ ] CHK-COV061 - Are coverage tool version requirements specified (which lcov/Codecov/tool versions)? [Gap]

### Automation & CI Integration

- [ ] CHK-COV062 - Is the automated coverage calculation requirement documented (CI computes % automatically)? [Completeness, Plan Phase 1]
- [ ] CHK-COV063 - Is the automated gate enforcement requirement documented (CI check fails if new code <80%)? [Completeness, Plan Phase 3]
- [ ] CHK-COV064 - Is the incremental coverage checking requirement documented (compare only changed files)? [Completeness, Plan Phase 3]
- [ ] CHK-COV065 - Is the coverage baseline management requirement documented (how baseline is set/updated)? [Gap]
- [ ] CHK-COV066 - Is the alert requirement documented (notify team if coverage drops significantly)? [Gap, Plan Phase 2+]

---

## Enforcement Timeline & Escalation

- [ ] CHK-COV067 - Is the enforcement timeline documented (report-only → soft gate → hard gate by dates)? [Completeness, Spec Phased Rollout, Plan Phases 0–3]
- [ ] CHK-COV068 - Is the enforcement escalation path documented (if <50% by Week 2, shift timeline by N weeks)? [Gap, Plan Risk Assessment]
- [ ] CHK-COV069 - Is the decision authority for timeline adjustments specified (who decides to extend/accelerate)? [Gap]
- [ ] CHK-COV070 - Is the communication plan for gate changes documented (announce deadline shifts ASAP)? [Gap]

---

## Validation & Audit

- [ ] CHK-COV071 - Is the quarterly coverage health review requirement documented? [Partially, Plan Phase 4]
- [ ] CHK-COV072 - Are metrics to review specified (trend, outliers, exceptions, tool accuracy)? [Gap]
- [ ] CHK-COV073 - Is the audit trail requirement documented (track all gate decisions, exceptions, overrides)? [Gap]
- [ ] CHK-COV074 - Is the accuracy validation requirement documented (spot-check coverage % manually)? [Gap]

---

## Stakeholder Communication

- [ ] CHK-COV075 - Is the team education requirement documented (how to interpret/improve coverage)? [Gap]
- [ ] CHK-COV076 - Are requirements for addressing coverage concerns documented (escalation, discussion path)? [Gap]
- [ ] CHK-COV077 - Is the new contributor onboarding requirement for coverage expectations documented? [Gap, Spec SC-006]
- [ ] CHK-COV078 - Is the public visibility requirement documented (are coverage metrics visible in README, badges)? [Gap, Plan Phase 1]

---

## Open Questions & Decision Points

- [ ] CHK-COV079 - Decision: Should legacy code be granted indefinite coverage exceptions, or firm deadline (Week 8)? [Open Decision, Plan Phase 3]
- [ ] CHK-COV080 - Decision: Should performance-critical path exceptions bypass hard gate, or require hard gate + documented justification? [Open Decision, Plan Phase 2]
- [ ] CHK-COV081 - Decision: Should coverage % be published publicly (README badge) or kept internal? [Open Decision, Plan Phase 1]
- [ ] CHK-COV082 - Decision: Are 50%/70%/80% targets achievable, or should they be adjusted based on Week 1–2 baseline? [Open Decision, Plan Phase 1]

---

## Validation Summary

**Overall Status**:
- **Documented**: 38 items (core targets, phases, basic process)
- **Partially Documented**: 12 items (mentioned in plan but could be clearer/more specific)
- **Gaps**: 32 items (missing details, workflows, metrics, automation)
- **Open Decisions**: 4 items (team consensus needed)

**High-Priority Clarifications Before Phase 0 Completion**:
1. CHK-COV009 — Quantify "90% critical flow" acceptance criteria
2. CHK-COV022 — Define "new code" for hard gate (modified files, new files, both)
3. CHK-COV027–CHK-COV031 — Document exception request workflow (template, approval authority)
4. CHK-COV057 — Clarify flaky test exclusion from coverage % calculations

**Medium-Priority (Phase 1 Implementation)**:
- CHK-COV015 — Per-platform coverage reporting setup
- CHK-COV018–CHK-COV020 — Soft gate approval process
- CHK-COV059–CHK-COV061 — Tool configuration documentation
- CHK-COV067–CHK-COV070 — Enforcement timeline communication plan

**Non-Blocking (Phase 2–4)**:
- CHK-COV040–CHK-COV048 — Dashboard, weekly/monthly reporting
- CHK-COV065–CHK-COV074 — Automation enhancements, auditing
- CHK-COV075–CHK-COV078 — Team communication, onboarding
- CHK-COV079–CHK-COV082 — Policy refinements post-Week 2 data

**Recommended Deliverables**:
1. Create `contracts/coverage-policy.md` (referenced in plan) documenting acceptance criteria, phases, exceptions, and enforcement process
2. Document coverage measurement methodology in `contracts/test-protocol.md` (tool configuration, exclusions, per-file tracking)
3. Create GitHub Issue templates for coverage exceptions (required fields, approval SLA)
4. Plan Phase 1 task: Set up coverage dashboard (Codecov or custom) with weekly report automation

